https://www.taxtmi.com/news?id=48633 Asston Pharmaceuticals Limited is launching an IPO on the SME Platform through a 100% book-building process, with specified price band, lot size, and scheduled anchor and public subscription dates. The issue allocates shares across anchor investors, Qualified Institutional Buyers, Non-Institutional Investors, Retail Individual Investors, and a Market Maker. Net proceeds are earmarked for machinery capex, working capital, debt repayment or prepayment, and general corporate purposes. The announcement names the lead manager and registrar, provides recent financial metrics, and contains a forward-looking statements disclaimer. en-us Mon, 07 Jul 2025 14:46:02 +0530 Mon, 07 Jul 2025 14:46:02 +0530 TaxTMI RSS Generator https://www.taxtmi.com/news?id=48633 Asston Pharmaceuticals Limited is launching an IPO on the SME Platform through a 100% book-building process, with specified price band, lot size, and scheduled anchor and public subscription dates. The issue allocates shares across anchor investors, Qualified Institutional Buyers, Non-Institutional Investors, Retail Individual Investors, and a Market Maker. Net proceeds are earmarked for machinery capex, working capital, debt repayment or prepayment, and general corporate purposes. The announcement names the lead manager and registrar, provides recent financial metrics, and contains a forward-looking statements disclaimer. News - Mon, 07 Jul 2025 14:46:02 +0530 https://www.taxtmi.com/news?id=48633